How the Formula Works: A Synergistic Approach to Longevity

The five ingredients in NMN Advanced Longevity are functionally interdependent. Each ingredient addresses a specific vulnerability in the cellular aging process, and several pairs interact directly to amplify one another’s effects. The following sections explain the science behind each component and how the blend’s synergies emerge.

NMN — Rebuilding the NAD+ Foundation

Nicotinamide mononucleotide (NMN) is a direct biosynthetic precursor to NAD+ (nicotinamide adenine dinucleotide), the coenzyme that sits at the center of cellular energy metabolism, DNA repair, and longevity signaling. NAD+ levels decline significantly with age, falling by as much as 50% between early adulthood and midlife in some tissue types. This decline can reduce mitochondrial efficiency, impair DNA repair, and diminish sirtuin activity. Clinical trials show that taking NMN orally can increase NAD+ levels in the blood. In a 2022 randomized controlled trial published in npj Aging and Mechanisms of Disease, participants who took NMN for 12 weeks had significantly higher whole-blood NAD+ levels. They also showed improvements in how their muscles responded to insulin and in measures of physical performance, particularly among older adults.

Trans-Resveratrol — Activating the Longevity Signaling Network

Resveratrol is a natural plant compound found in foods like grape skins. It’s of interest in longevity research because it can activate sirtuins, a group of enzymes linked to lifespan extension in multiple organisms. Resveratrol activates SIRT1, which helps regulate genes involved in inflammation, mitochondrial function, and cellular stress resistance. Importantly, this process depends on NAD+, meaning resveratrol’s effects rely on adequate NAD+ availability. That’s why combining it with NMN, which helps raise NAD+ levels, makes biological sense, rather than simply stacking two unrelated supplements.

TMG (Trimethylglycine) — Protecting Methylation Balance

As NMN is converted to NAD+, the metabolic pathway consumes methyl groups—a biochemical resource that is also essential for DNA methylation, neurotransmitter synthesis, and homocysteine clearance. High-level NMN supplementation without methyl donor support can, over time, draw down the body’s methylation capacity. TMG (trimethylglycine, also known as betaine) is one of the body’s primary methyl donors. By including TMG in each capsule of NMN Advanced Longevity, the formula ensures that methyl group availability scales alongside NMN intake, thus maintaining methylation homeostasis across the full range of daily servings.

Quercetin — Preserving NAD+ and Clearing Senescent Cells

Quercetin is a flavonoid present in many plants and vegetables that plays two distinct and complementary roles in this formula. First, it is a well-characterized inhibitor of CD38, an enzyme that degrades NAD+ and whose activity increases substantially with age. Research has demonstrated that age-related NAD+ decline is driven in significant part by increased CD38 activity rather than decreased biosynthesis alone, making CD38 inhibition a meaningful strategy for preserving NAD+ availability. By inhibiting CD38, quercetin helps protect the NAD+ that NMN works to generate. Second, quercetin has senolytic properties, allowing it to selectively promote the clearance of senescent cells that accumulate with age and contribute to chronic low-grade inflammation. This dual role makes quercetin a functionally rich addition to a longevity-focused formula.

Piperine — Maximizing Polyphenol Bioavailability

Resveratrol and quercetin are both well-studied, but they share a common drawback: poor absorption when taken orally. After ingestion, the intestines and liver quickly break them down, which limits how much actually reaches the bloodstream.

Piperine—the active compound in black pepper—can help address this. It slows down the enzymes and transport systems (like cytochrome P450 enzymes and P-glycoprotein) that normally break down and clear these compounds. As a result, more resveratrol and quercetin remain available to circulate in the body and reach target tissues.

Research shows that piperine can significantly increase the bioavailability of both compounds. A 95% piperine extract provides a standardized, concentrated dose to support this effect.

A Scalable Serving Structure

NMN Advanced Longevity includes all five ingredients in every capsule in balanced proportions. The formula maintains its full design—supporting NAD+ production, activating sirtuins, providing methyl donors, inhibiting CD38, and enhancing bioavailability—at any serving size.

One capsule offers a lower-intensity option, making it a practical starting point for those new to longevity supplements or anyone who prefers a more conservative approach. Two capsules provide a moderate level, while three capsules deliver the full 1,500 mg blend at amounts most consistent with longevity research.

Piperine is included in every capsule, so bioavailability support remains in effect regardless of how many capsules are taken.

References

• https://pmc.ncbi.nlm.nih.gov/articles/PMC9158788
• https://www.science.org/doi/10.1126/science.aac4854
• https://pmc.ncbi.nlm.nih.gov/articles/PMC6342515
• https://pmc.ncbi.nlm.nih.gov/articles/PMC9512238
• https://pmc.ncbi.nlm.nih.gov/articles/PMC7238909
• https://www.sciencedirect.com/science/article/pii/S2161831323013595
• https://pmc.ncbi.nlm.nih.gov/articles/PMC11473484
• https://www.nature.com/articles/s44324-025-00067-0
• https://pmc.ncbi.nlm.nih.gov/articles/PMC7277745
• https://pmc.ncbi.nlm.nih.gov/articles/PMC8224793
• https://pmc.ncbi.nlm.nih.gov/articles/PMC9861325
• https://www.researchgate.net/figure/CD38-inhibition-by-quercetin-increases-NAD-levels-in-cells-A-Endogenous-CD38-NAD_fig6_233746160
• https://pmc.ncbi.nlm.nih.gov/articles/PMC12155388
• https://www.nature.com/articles/s41598-021-02544-0
• https://pmc.ncbi.nlm.nih.gov/articles/PMC12341813
• https://pmc.ncbi.nlm.nih.gov/articles/PMC7910313
• https://pmc.ncbi.nlm.nih.gov/articles/PMC3295233
• https://pmc.ncbi.nlm.nih.gov/articles/PMC11023993
• https://article.imrpress.com/journal/IJP/8/2/10.3923/ijp.2012.101.107/fb85c68834875e135c38e7c89e45f845.pdf